Medicine and Dentistry
Neuromyelitis Optica
69%
Disease
46%
Global Disease Burden
46%
Multiple Sclerosis
42%
Optical Coherence Tomography
23%
Randomized Controlled Trial
23%
Patient with Type 2 Diabetes
23%
Maturity Onset Diabetes of the Young
22%
Meta-Analysis
20%
Cohort Analysis
20%
Optic Neuritis
19%
COVID-19
18%
Quality of Life
15%
Aquaporin 4 Antibody
15%
Disease Activity
14%
Adverse Event
14%
Retinal Nerve Fiber Layer
13%
Multiple Chronic Conditions
13%
Patient-Reported Outcome
13%
Diabetes
13%
Ganglion
12%
Inner Plexiform Layer
12%
Placebo
12%
Systematic Review
12%
Alzheimer's Disease
12%
Cardiovascular Disease
12%
Prevalence
11%
Subclinical Hypothyroidism
11%
Empagliflozin
11%
Heart Muscle Blood Flow
11%
Kinesiotherapy
11%
Sequential Analysis
11%
Systematic Review with Meta-Analysis
11%
Primary Health Care
11%
Cataract
11%
Randomized Clinical Trial
10%
Apoplexy
10%
Spinal Cord Injury
9%
Congestive Heart Failure
8%
Aerobic Exercise
8%
Type 2 Diabetes
7%
Drug Therapy
7%
Expanded Disability Status Scale
7%
Diagnosis
7%
Cardiac Fibrosis
7%
Cross Sectional Study
7%
Progeny
7%
Respiratory Tract Infection
7%
Population Research
7%
Biological Marker
7%
Life Expectancy
6%
Onset Age
6%
Cardiovascular Risk
6%
Injury
6%
Meningitis
6%
Recurrence Risk
6%
Sodium Glucose Cotransporter 2 Inhibitor
6%
Hazard Ratio
6%
Medical Research
6%
Clinical Trial
6%
Disability Adjusted Life Years
5%
Personalized Medicine
5%
Disability Pension
5%
Shared Care
5%
Neurofilament
5%
Parkinson's Disease
5%
Mitochondrion
5%
Outer Plexiform Layer
5%
Fumaric Acid Dimethyl Ester
5%
Water-Electrolyte Imbalance
5%
Neuroinflammation
5%
Vascular Dementia
5%
Neuropathic Pain
5%
Cord Blood
5%
Maternal Blood
5%
Obstetrics
5%
Mental Health Care
5%
Thyroid Gland
5%
Adipose Tissue
5%
Systolic Dysfunction
5%
Hemodynamic
5%
Spasmodic torticollis
5%
microRNA
5%
Prospective Cohort Study
5%
Spasticity
5%
Diastolic Function
5%
Cannabis
5%
Myeloid Cell
5%
Medicine
5%
Informal Carer
5%
Care Coordination
5%
Communicable Disease
5%
Semaglutide
5%
Prognostication
5%
Clinical Research
5%
Mental Capacity
5%
Demography
5%
Sex Ratio
5%
Neurological System
5%
Traffic Noise
5%
Pharmacology, Toxicology and Pharmaceutical Science
Myelooptic Neuropathy
55%
Global Disease Burden
52%
Disease
41%
Multiple Sclerosis
31%
Non Insulin Dependent Diabetes Mellitus
24%
Prevalence
17%
Placebo
15%
Adverse Event
15%
Subclinical Hypothyroidism
11%
Parkinson's Disease
10%
Expanded Disability Status Scale
10%
Cerebrovascular Accident
9%
Comorbidity
9%
Spinal Cord Injury
9%
Aquaporin 4 Antibody
8%
Alzheimer's Disease
7%
Rituximab
7%
Disease Exacerbation
7%
Disease Activity
7%
Meningitis
7%
Respiratory Tract Infection
7%
Pandemic
7%
Life Expectancy
6%
Cohort Study
6%
Inflammatory Disease
6%
Recurrence Risk
6%
Injury
5%
Sodium Glucose Cotransporter 2
5%
Cervical Dystonia
5%
Systolic Dysfunction
5%
Insulin Dependent Diabetes Mellitus
5%
Diabetic Ketoacidosis
5%
Tetramethylrhodamine Methyl Ester
5%
Fumaric Acid Dimethyl Ester
5%
Empagliflozin
5%
Hearing Impairment
5%
Communicable Disease
5%
Prospective Cohort Study
5%
Diabetic Complication
5%
Cross-Sectional Study
5%
Heart Muscle Fibrosis
5%
Myelin Oligodendrocyte Glycoprotein
5%
Spasticity
5%
Neuropathic Pain
5%
microRNA
5%
Citalopram
5%
Cannabis
5%
Semaglutide
5%
Clinical Research
5%
Onset Age
5%
Cataract
5%
Clostridium Botulinum Type A
5%
Cardiovascular Disease
5%
Vitamin D
5%
Teriflunomide
5%
Neuroscience
Neuromyelitis Optica
100%
Optic Neuritis
52%
Multiple Sclerosis
38%
Astrocyte
21%
Aquaporin 4 Antibody
18%
Myelin Oligodendrocyte Glycoprotein
15%
Aquaporin 4
12%
Hypothyroidism
12%
Parkinson's Disease
11%
Angiotensin II Receptor Type 2
11%
Demyelinating Disease
11%
Meta-Analysis
11%
Cerebrovascular Accident
11%
Central Nervous System
10%
Intrathecal
9%
Autoantibodies
8%
Rituximab
7%
Nerve Fiber
7%
Comorbidity
7%
Glial Fibrillary Acidic Protein
7%
Mitochondrion
7%
Behavior (Neuroscience)
7%
Placebo
7%
Interferon
6%
Ganglion Cell
6%
Interleukin 10
6%
Alzheimer's Disease
6%
Microglia
6%
Neurofilament
6%
Optic Nerve
6%
Methyl Ester
5%
Brain-Derived Neurotrophic Factor
5%
Cognitive Therapy
5%
CXCL13
5%
Amyotrophic Lateral Sclerosis
5%
Sensation of Hearing
5%
Thyroid
5%
MicroRNA
5%
Neuropathic Pain
5%
Adipose Tissue
5%
Neuritis
5%
Cannabis
5%
Clostridium Botulinum Type A
5%